Compare Novavax Inc (NVAX) vs Palo Alto Networks Inc (PANW) Price & Performance

Novavax IncTrade

Palo Alto Networks IncTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Palo Alto Networks Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Palo Alto Networks Inc trades at $342.49 (market cap $284.16B). The key difference: Palo Alto Networks Inc is far larger — about 218.6× Novavax Inc's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.

	NVAX	PANW
Market Cap	$1.30B	$284.16B
Sector	Health	Technology
52-Week High	$11.19	$358.68
52-Week Low	$6.22	$141.67
Enterprise Value	$800.50M	$283.12B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

PANW

Palo Alto Networks to acquire Embrace, adding Real User Monitoring and Synthetics to boost app performance insights.PRNewsWire · 5 hours agoBullish Argus Research raises Palo Alto Networks price target to $425 on booming AI-driven cybersecurity demand.Danny Green · 7 hours agoBullish Cybersecurity ETFs soar as investors shift from semiconductors amid rising cyber threats and AI risks.ETF Trends · 7 hours agoBullish View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.